Boston Scientific Announces Results For First Quarter 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
Go back to Boston Scientific Announces Results For First Quarter 2016
April 27, 2016 2:13 PM EDT
Needham & Company analyst Mike Matson reiterated a Buy rating and boosted his price target on Boston Scientific (NYSE: BSX) to $26.00 (from $22.00), saying Q1 marks and inflection point for growth and margins.
Matson commented, "BSX beat consensus 1Q16 revenue and EPS by a wide margin.... More
April 27, 2016 9:53 AM EDT
Boston Scientific (NYSE: BSX) is strong out of the gate following better-than-expected earnings and a raised outlook. Shares last traded up 8.9%.
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the... More
April 27, 2016 6:32 AM EDT
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $1.96 billion versus the consensus estimate of $1.91 billion.
GUIDANCE:
Boston Scientific sees Q2 2016 EPS of $0.25-$0.27, versus the consensus of $0.26.... More
